A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

The world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity.

The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...